Analysis of cytotoxic activity of the CD4+ T lymphocytes generated by local immunotherapy
1996

Cytotoxic Activity of CD4+ T Lymphocytes from Thyroid Cancer Patients

Sample size: 7 publication Evidence: moderate

Author Information

Author(s): Y Katsumoto, T Monden, T Takeda, A Haba, Y Ito, E Wakasugi, T Wakasugi, M Sekimoto, T Kobayashi, H Shiozaki, T Shimano, M Monden

Primary Institution: Osaka University Medical School

Hypothesis

The study investigates the characteristics and killing mechanisms of cytotoxic CD4+ T lymphocytes generated by local immunotherapy with OK-432 and fibrinogen.

Conclusion

The study concludes that ICAM-1 on cytotoxic CD4+ T lymphocytes enhances their IFN-y secretion and cytolytic activity.

Supporting Evidence

  • The generated CD4+ T cells secreted high levels of IFN-y and TNF-P.
  • CD4+ T cells exhibited high cytolytic activity against various tumor cell lines.
  • ICAM-1 expression on T cells was crucial for enhancing their cytotoxic activity.

Takeaway

Doctors can make special immune cells from thyroid cancer patients to help fight tumors better, and a molecule called ICAM-1 helps these cells work harder.

Methodology

The study involved generating cytotoxic CD4+ T lymphocytes from tumor-infiltrating lymphocytes of thyroid cancer patients treated with local immunotherapy, followed by phenotypic analysis and cytotoxicity assays.

Participant Demographics

Patients with thyroid cancer who received local immunotherapy.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication